United States Prostate Cancer Market Report 2018

February 2018 | 101 pages | ID: UFEDB66C370EN
QYResearch

Abstracts

In this report, the United States Prostate Cancer market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Prostate Cancer in these regions, from 2013 to 2025 (forecast).

United States Prostate Cancer market competition by top manufacturers/players, with Prostate Cancer sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas
• AstraZeneca
• Johnson & Johnson
• Sanofi
• Bristol Myers Squibb
• Bayer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormone sensitive prostate cancer
• Hormone refractory prostate cancer

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Chemotherapy
• Hormonal Therapy
• Targeted Therapy
• Immunotherapy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Prostate Cancer Market Report 2018

1 PROSTATE CANCER OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer
1.2 Classification of Prostate Cancer by Product Category
  1.2.1 United States Prostate Cancer Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Prostate Cancer Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Hormone sensitive prostate cancer
  1.2.4 Hormone refractory prostate cancer
1.3 United States Prostate Cancer Market by Application/End Users
  1.3.1 United States Prostate Cancer Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Chemotherapy
  1.3.3 Hormonal Therapy
  1.3.4 Targeted Therapy
  1.3.5 Immunotherapy
1.4 United States Prostate Cancer Market by Region
  1.4.1 United States Prostate Cancer Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Prostate Cancer Status and Prospect (2013-2025)
  1.4.3 Southwest Prostate Cancer Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Prostate Cancer Status and Prospect (2013-2025)
  1.4.5 New England Prostate Cancer Status and Prospect (2013-2025)
  1.4.6 The South Prostate Cancer Status and Prospect (2013-2025)
  1.4.7 The Midwest Prostate Cancer Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Prostate Cancer (2013-2025)
  1.5.1 United States Prostate Cancer Sales and Growth Rate (2013-2025)
  1.5.2 United States Prostate Cancer Revenue and Growth Rate (2013-2025)

2 UNITED STATES PROSTATE CANCER MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Prostate Cancer Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Prostate Cancer Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Prostate Cancer Average Price by Players/Suppliers (2013-2018)
2.4 United States Prostate Cancer Market Competitive Situation and Trends
  2.4.1 United States Prostate Cancer Market Concentration Rate
  2.4.2 United States Prostate Cancer Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Prostate Cancer Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROSTATE CANCER SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Prostate Cancer Sales and Market Share by Region (2013-2018)
3.2 United States Prostate Cancer Revenue and Market Share by Region (2013-2018)
3.3 United States Prostate Cancer Price by Region (2013-2018)

4 UNITED STATES PROSTATE CANCER SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Prostate Cancer Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Prostate Cancer Revenue and Market Share by Type (2013-2018)
4.3 United States Prostate Cancer Price by Type (2013-2018)
4.4 United States Prostate Cancer Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PROSTATE CANCER SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Prostate Cancer Sales and Market Share by Application (2013-2018)
5.2 United States Prostate Cancer Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROSTATE CANCER PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Astellas
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostate Cancer Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Prostate Cancer Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.2 Prostate Cancer Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Prostate Cancer Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bristol Myers Squibb
  6.5.2 Prostate Cancer Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol Myers Squibb Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.2 Prostate Cancer Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Prostate Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview

7 PROSTATE CANCER MANUFACTURING COST ANALYSIS

7.1 Prostate Cancer Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Cancer

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Cancer Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Cancer Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROSTATE CANCER MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Prostate Cancer Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Prostate Cancer Sales Volume Forecast by Type (2018-2025)
11.3 United States Prostate Cancer Sales Volume Forecast by Application (2018-2025)
11.4 United States Prostate Cancer Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer
Figure United States Prostate Cancer Market Size (MT) by Type (2013-2025)
Figure United States Prostate Cancer Sales Volume Market Share by Type (Product Category) in 2017
Figure Hormone sensitive prostate cancer Product Picture
Figure Hormone refractory prostate cancer Product Picture
Figure United States Prostate Cancer Market Size (MT) by Application (2013-2025)
Figure United States Sales Market Share of Prostate Cancer by Application in 2017
Figure Chemotherapy Examples
Table Key Downstream Customer in Chemotherapy
Figure Hormonal Therapy Examples
Table Key Downstream Customer in Hormonal Therapy
Figure Targeted Therapy Examples
Table Key Downstream Customer in Targeted Therapy
Figure Immunotherapy Examples
Table Key Downstream Customer in Immunotherapy
Figure United States Prostate Cancer Market Size (Million USD) by Region (2013-2025)
Figure The West Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Sales (MT) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Market Major Players Product Sales Volume (MT) (2013-2018)
Table United States Prostate Cancer Sales (MT) of Key Players/Suppliers (2013-2018)
Table United States Prostate Cancer Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Prostate Cancer Sales Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Sales Share by Players/Suppliers
Figure United States Prostate Cancer Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Prostate Cancer Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Prostate Cancer Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Prostate Cancer Revenue Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Revenue Share by Players/Suppliers
Table United States Market Prostate Cancer Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Prostate Cancer Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Prostate Cancer Market Share of Top 3 Players/Suppliers
Figure United States Prostate Cancer Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Prostate Cancer Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Prostate Cancer Product Category
Table United States Prostate Cancer Sales (MT) by Region (2013-2018)
Table United States Prostate Cancer Sales Share by Region (2013-2018)
Figure United States Prostate Cancer Sales Share by Region (2013-2018)
Figure United States Prostate Cancer Sales Market Share by Region in 2017
Table United States Prostate Cancer Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Prostate Cancer Revenue Share by Region (2013-2018)
Figure United States Prostate Cancer Revenue Market Share by Region (2013-2018)
Figure United States Prostate Cancer Revenue Market Share by Region in 2017
Table United States Prostate Cancer Price (USD/MT) by Region (2013-2018)
Table United States Prostate Cancer Sales (MT) by Type (2013-2018)
Table United States Prostate Cancer Sales Share by Type (2013-2018)
Figure United States Prostate Cancer Sales Share by Type (2013-2018)
Figure United States Prostate Cancer Sales Market Share by Type in 2017
Table United States Prostate Cancer Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Prostate Cancer Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Prostate Cancer by Type (2013-2018)
Figure Revenue Market Share of Prostate Cancer by Type in 2017
Table United States Prostate Cancer Price (USD/MT) by Types (2013-2018)
Figure United States Prostate Cancer Sales Growth Rate by Type (2013-2018)
Table United States Prostate Cancer Sales (MT) by Application (2013-2018)
Table United States Prostate Cancer Sales Market Share by Application (2013-2018)
Figure United States Prostate Cancer Sales Market Share by Application (2013-2018)
Figure United States Prostate Cancer Sales Market Share by Application in 2017
Table United States Prostate Cancer Sales Growth Rate by Application (2013-2018)
Figure United States Prostate Cancer Sales Growth Rate by Application (2013-2018)
Table Astellas Basic Information List
Table Astellas Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Astellas Prostate Cancer Sales Growth Rate (2013-2018)
Figure Astellas Prostate Cancer Sales Market Share in United States (2013-2018)
Figure Astellas Prostate Cancer Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AstraZeneca Prostate Cancer Sales Growth Rate (2013-2018)
Figure AstraZeneca Prostate Cancer Sales Market Share in United States (2013-2018)
Figure AstraZeneca Prostate Cancer Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Johnson & Johnson Prostate Cancer Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Prostate Cancer Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Prostate Cancer Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Prostate Cancer Sales Growth Rate (2013-2018)
Figure Sanofi Prostate Cancer Sales Market Share in United States (2013-2018)
Figure Sanofi Prostate Cancer Revenue Market Share in United States (2013-2018)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol Myers Squibb Prostate Cancer Sales Growth Rate (2013-2018)
Figure Bristol Myers Squibb Prostate Cancer Sales Market Share in United States (2013-2018)
Figure Bristol Myers Squibb Prostate Cancer Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Prostate Cancer Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer Prostate Cancer Sales Growth Rate (2013-2018)
Figure Bayer Prostate Cancer Sales Market Share in United States (2013-2018)
Figure Bayer Prostate Cancer Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer
Figure Manufacturing Process Analysis of Prostate Cancer
Figure Prostate Cancer Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Major Players/Suppliers in 2017
Table Major Buyers of Prostate Cancer
Table Distributors/Traders List
Figure United States Prostate Cancer Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Prostate Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Prostate Cancer Price (USD/MT) Trend Forecast (2018-2025)
Table United States Prostate Cancer Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Prostate Cancer Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Prostate Cancer Sales Volume (MT) Forecast by Type in 2025
Table United States Prostate Cancer Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Prostate Cancer Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Prostate Cancer Sales Volume (MT) Forecast by Application in 2025
Table United States Prostate Cancer Sales Volume (MT) Forecast by Region (2018-2025)
Table United States Prostate Cancer Sales Volume Share Forecast by Region (2018-2025)
Figure United States Prostate Cancer Sales Volume Share Forecast by Region (2018-2025)
Figure United States Prostate Cancer Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources